VAR
Varian Medical Systems, Inc.
Set alert
— — —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 16.26B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 29.66
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2021
- 50-d avg
- 176.57
- 200-d avg
- 174.89
- 1y target
- 177.67
Key statistics
- Market cap
- 16.26B
- Trailing P/E
- 58.40
- Forward P/E
- 29.66
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 176.57
- 200-day average
- 174.89
Analyst view
Consensus: hold
Hold
Price target (mean) 177.67
- Target (low)
- 177.50
- Target (mean)
- 177.67
- Target (high)
- 178.00
Ratings (0m) 8 2 buy · 6 hold · 0 sell
- Strong buy2
- Buy0
- Hold6
- Sell0
- Strong sell0
Next earnings
May 3, 2021
Expected May 3, 2021. Consensus EPS estimate 1.15.
Financials — quick view
VAR Revenue — quarterly 778.80M
VAR Net income — quarterly 96.50M
VAR EPS — quarterly 1.06
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 3, 2021 | Mar 1, 2021 | 1.19 | — | — | — |
| Jan 26, 2021 | Dec 1, 2020 | 1.04 | — | — | — |
| Oct 27, 2020 | Sep 1, 2020 | 0.98 | — | — | — |
| Aug 2, 2020 | Jun 1, 2020 | 0.55 | — | — | — |
| May 4, 2020 | Mar 1, 2020 | 0.84 | — | — | — |
| Jan 29, 2020 | Dec 1, 2019 | 1.21 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 7, 2020 | Jefferies | down | Buy | Hold |
| Oct 28, 2020 | Baird | down | Outperform | Neutral |
| Aug 11, 2020 | BTIG | down | Buy | Neutral |
| Aug 3, 2020 | Jefferies | main | — | Buy |
| Aug 3, 2020 | Evercore ISI Group | up | Underperform | In-Line |
| Jul 27, 2020 | Piper Sandler | main | — | Overweight |
News
- Varian Announces CE Mark for Embozene in Genicular Artery Embolisation, Expanding Treatment for Knee Osteoarthritis
- Varian Completes Enrollment and Treatment in FAST-02 Clinical Trial of Flash Therapy in Treating Thoracic Bone Metastases
- Varian's RapidArc Dynamic Solution Unlocks New Dimensions in Treatment Planning and Delivery
- Varian Announces 10-year Transformational Oncology Collaboration with Ballad Health to Bring Advanced Treatment Solutions to Rural Communities
- Varian Launches HyperSight™ for TrueBeam in Asia Pacific: Boosting Accuracy and Efficiency in Radiotherapy Treatment
- Siemens Healthineers Q1 sales beat expectations on strong Varian unit
- Siemens Healthineers bets on Varian to boost growth
- PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600
- Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year
- Varian (VAR) Inks Deal With Google Cloud to Boost Cancer Care
Your note
Sign in to keep a note on VAR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BALSER JEFFREY R M.D., PH.D. | Director | Conversion of Exercise of derivative security | Feb 15, 2021 | 2,824 |
| BRUFF JESSE MICHAEL | Chief Financial Officer | Sale | Feb 28, 2021 | 823 |
| BRUNER JUDY | Director | Conversion of Exercise of derivative security | Feb 15, 2021 | 6,779 |
| BUTEL JEAN LUC | Director | Conversion of Exercise of derivative security | Feb 15, 2021 | 4,048 |
| DUGAN REGINA E | Director | Conversion of Exercise of derivative security | Feb 15, 2021 | 12,396 |
| ECKERT ROBERT ANDREW | Director | Conversion of Exercise of derivative security | Feb 15, 2021 | 14,273 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 10.63% | 9,765,102 | 1.71B | Dec 30, 2020 |
| Blackrock Inc. | 8.07% | 7,409,101 | 1.30B | Dec 30, 2020 |
| State Street Corporation | 4.23% | 3,885,726 | 680.04M | Dec 30, 2020 |
| Bank Of Nova Scotia / | 1.93% | 1,776,800 | 310.96M | Dec 30, 2020 |
| Millennium Management LLC | 1.67% | 1,534,026 | 268.47M | Dec 30, 2020 |
| Geode Capital Management, LLC | 1.64% | 1,508,609 | 264.02M | Dec 30, 2020 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.81% | 2,583,521 | 452.14M | Dec 30, 2020 |
| Vanguard Mid-Cap Index Fund | 2.25% | 2,064,576 | 361.32M | Dec 30, 2020 |
| Vanguard 500 Index Fund | 1.99% | 1,830,495 | 320.35M | Dec 30, 2020 |
| Merger Fund, The | 1.13% | 1,037,433 | 181.56M | Dec 30, 2020 |
| Janus Henderson Enterprise Fund | 1.10% | 1,012,999 | 177.28M | Dec 30, 2020 |
| SPDR S&P 500 ETF Trust | 1.04% | 954,500 | 168.50M | Mar 30, 2021 |